Follow us on Facebook!
Follow us on Twitter!
Follow us on Youtube!
MPE Telegram channel on COVID-19

 

Summary of international recommendations for cancer patients during the COVID-19 pandemic

Read this summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic published by The Lancet Oncology. Read more.

 

#PAGC19

PatientView has been researching the views and needs of patient groups worldwide and they are using their network to track the needs and actions of patient groups as they adapt to the demands of Covid-19 by collating the various communications and tweets under the hashtag #PAGC19. Read more.

 

New clinical trial to evaluate the myeloma drug selinexor as potential treatment for patients with COVID-19

The pharmaceutical company, Karyopharm Therapeutics has announced plans to initiate a global randomized clinical trial for low dose oral selinexor in hospitalized patients with severe COVID-19 (coronavirus). Selinexor, marketed as XPOVIO®, is currently approved at higher doses by the Food and Drug Administration (FDA) as a treatment for patients with relapsed or refractory multiple myeloma. Read more.

 

COVID-19 treatment in myeloma patients

A case study of a patient in Wuhan, China, suggests that the immunosuppressant tocilizumab may be an effective COVID-19 treatment for very ill patients who also have myeloma and other blood cancers. Read more.

 

MPE advice sheet on COVID-19

Myeloma Patients Europe (MPE) has put together an advice sheet for our members and myeloma patients on COVID-19 (coronavirus). This advice has been reviewed by our scientific advisors and will be continually updated to reflect the latest information. Read more.

 

Workgroup of European Cancer Patient Advocacy Network (WECAN) and COVID-19

Many WECAN member organisations are providing informational resources about COVID-19 and about specific recommendations to their patient community. Here you find links to the COVID-19 resources provided on the websites of those patient organisations, which may link to additional relevant articles and tools for their specific disease area. Read more.

 


International Academy for Clinical Hematology (IACH) Webinar on COVID-19

Recording of the webinar held by the International Academy for Clinical Hematology (IACH) on COVID-19. The webinar was given by Prof. Mohamad Mohty and Prof. Marivi Mateos. Watch it here.

 

ESMO myeloma management and treatment recommendations in the COVID-19 era

These recommendations aim to develop guidance to mitigate the negative effects of the COVID-19 pandemic on the diagnosis and treatment of myeloma patients. Read more.

 

ASCO COVID-19 patient care information

The American Society of Clinical Oncology (ASCO) patient information website has regularly updated information about COVID-19 for people with cancer and cancer survivors in English and Spanish. Read more.

 

ESMO – COVID-19 and cancer

The European Society for Medical Oncology (ESMO) is supporting oncology professionals by gathering information and resources on COVID-19 Read more.

 

WHO – COVID-19 pandemic

Read here the latest information provided by the World Health Organisation (WHO) regarding COVID-19. Read more.

 

EUROBLOODNET – COVID-19 and rare hematological diseases

At this crucial stage, efforts are being devoted by different initiatives for the generation of documents with indications for the clinical care of these patients. Find here some of the documents produced with the participation of EuroBloodNet members, including language and target (health professionals or patients). Read more.

 

American Society of Hematology (ASH) and COVID-19

The United States and countries around the world face a major public health concern with the current outbreak of the novel COVID-19. In an effort to serve its members, ASH is maintaining this webpage as a medium to exchange information to assist hematologists in navigating the COVID-19 public health crisis. Read more.

 

European Hematology Association (EHA) Recommendations for hematologists in COVID-19 crisis

In view of the rapidly changing evidence and general situation the EHA Scientific Working Group Infections in Hematology has developed key questions and answers on the management of cancer patients with or at risk of COVID-19. Read more.